药物治疗状体和高变性痕的药物治疗
Teruo Murakami1, Sadayuki Shigeki2
1Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hiroshima International University, Higashi-Hiroshima 731-2631, Japan.
International journal of molecular sciences
|May 11, 2024
概括
治疗状体 (KD) 和缩性痕 (HTS) 的药物治疗仍在发展. 针对多种途径的组合治疗比单药疗法更有前途,可以改善患者的生活质量.
科学领域:
- 皮肤病学 皮肤病学
- 伤口愈合 治愈 伤口愈合
- 药理学 药理学是指药理学的学科.
背景情况:
- 状体 (KD) 和缩性痕 (HTS) 是由于异常的皮肤伤口愈合而产生的,受遗传学影响.
- 这些凸起的,有色素的痕严重损害了患者的生活质量,原因是疼痛,和美容问题.
- 目前KD和HTS的治疗方法正在开发中,以更好地满足患者的需求.
研究的目的:
- 审查药物治疗选择,以治疗状体和过度缩的痕.
- 评估药物疗法,以预防手术后状体的复发.
- 探索单疗法和组合药物治疗方法.
主要方法:
- 使用PubMed,谷歌学者和在线搜索引擎进行文学搜索.
- 对口服,局部和通过内伤注射的药物治疗的审查.
- 考虑药物治疗与外科切除和物理疗法 (冷疗法,激光,放射疗法,) 结合.
主要成果:
- 对于KD/HTS的单疗法的临床有效性在不同研究中有所不同.
- 多模式组合药物治疗显示出比单一治疗更大的疗效.
- 药物治疗在治疗KD/HTS和预防复发方面发挥着作用.
结论:
- 针对多个部位的组合药物治疗对于KD/HTS管理更有效.
- 需要进一步的研究来优化药物治疗,以改善患者的治疗结果和生活质量.
- 药物治疗,通常与其他疗法结合,是治疗和预防 keloids 和高性痕的关键策略.
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
157
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338
Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89


